Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.
DRNAShowing 0 of 5 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in DICERNA PHARMACEUTICALS INC
No. RA Capital Management exited its DRNA (Dicerna Pharmaceuticals) position in Q4 2019. Its Q3 2019 13F listed 2,456,669 shares worth $35.3M. RA Capital Management already held DRNA in its Q4 2018 13F, the earliest on record, and held it in 4 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DRNA: RTW INVESTMENTS, LP